TRDA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

TRDAEntrada Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

TRDAEntrada Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TRDA

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±56.7%▼−2.49%×0.04

May 7 '26±24.3%▼−57.27%×2.36

Q1 FY26±38.0%▲+6.76%×0.18

Jan 8 '26±42.8%▼−2.14%×0.05

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedTRDA realized, solidLLY realized, hatchedOne scale, both sides: full bar = 58%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

TRDAEntrada Therapeutics, Inc.

4.63▲+2.09%

Mkt cap$176.6MRevenue$898,000Q2 FY26Revenue$25MFY25

LLYELI Lilly & Co

1,407.61▼−0.70%

Regular sessionNov 2 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 2 '26

TRDAEntrada Therapeutics, Inc.

LLYELI Lilly & Co

4.63▲+2.09%

Price

1,407.61▼−0.70%

$176.6M

Mkt cap

$1.3T

Q2 FY26$898,000

Revenue

$24.4BQ3 FY26

FY25$25M

Revenue

$65.2BFY25

TRDA4.63▲+2.09%vsLLY1,407.61▼−0.70%Regular sessionNov 2 '26